Literature DB >> 17942768

Genetic factors in diabetic nephropathy.

Barry I Freedman1, Meredith Bostrom, Pirouz Daeihagh, Donald W Bowden.   

Abstract

Several genes that predispose to type 2 diabetes have recently been identified. In addition to the recognized and powerful effects of environmental factors, there is abundant evidence in support of genetic susceptibility to the microvascular complication of nephropathy in individuals with both type 1 and type 2 diabetes. Familial aggregation of phenotypes such as end-stage renal disease, albuminuria, and chronic kidney disease have routinely been reported in populations throughout the world, and heritability estimates for albuminuria and glomerular filtration rate demonstrate strong contributions of inherited factors. Recent genome-wide linkage scans have identified several chromosomal regions that likely contain diabetic nephropathy susceptibility genes, and association analyses have evaluated positional candidate genes under these linkage peaks. These complimentary approaches have demonstrated that polymorphisms in the carnosinase 1 gene on chromosome 18q, the adiponectin gene on 3q, and the engulfment and cell motility gene on 7p are likely associated with susceptibility to diabetic nephropathy. Additional genes that seem to be of importance in renal phenotypes include manganese superoxide dismutase and angiotensin 1-converting enzyme, with nitric oxide synthase implicated in albuminuria. This article reviews the inherited aspects of diabetic kidney disease with particular emphasis on recently implicated genes and pathways. It seems likely that the risk for diabetes-associated kidney disease is magnified by inheriting risk alleles at several susceptibility loci, in the presence of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942768     DOI: 10.2215/CJN.02560607

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  78 in total

1.  Successes achieved and challenges ahead in translating biomarkers into clinical applications.

Authors:  Greg Tesch; Shashi Amur; John T Schousboe; Jeffrey N Siegel; Lawrence J Lesko; Jane P F Bai
Journal:  AAPS J       Date:  2010-03-16       Impact factor: 4.009

2.  Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.

Authors:  Isai Gopalakrishnan; Samy S Iskandar; Pirouz Daeihagh; Jasmin Divers; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Michael V Rocco; Barry I Freedman
Journal:  Hum Pathol       Date:  2010-11-13       Impact factor: 3.466

Review 3.  APOE polymorphism and diabetic nephropathy.

Authors:  Shin-ichi Araki
Journal:  Clin Exp Nephrol       Date:  2013-09-13       Impact factor: 2.801

4.  How to survive diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2009-04       Impact factor: 10.122

5.  Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy.

Authors:  Tao Wang; Yan Zhang; Ning Wang; Qiong Liu; ZeKai Wang; Bing Liu; Kai Niu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

6.  Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy.

Authors:  Dongying Zhang; Barry I Freedman; Milan Flekac; Elisabete Santos; Pamela J Hicks; Donald W Bowden; Suad Efendic; Kerstin Brismar; Harvest F Gu
Journal:  Am J Nephrol       Date:  2008-09-19       Impact factor: 3.754

7.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Comeau; Jasmin Divers; Anthony J Bleyer; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2009-06-30       Impact factor: 5.992

8.  Investigating the effect of genetic background on proteinuria and renal injury using two hypertensive strains.

Authors:  Matthew Packard; Yasser Saad; William T Gunning; Shalini Gupta; Joseph Shapiro; Michael R Garrett
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-28

9.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

10.  The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes.

Authors:  Limei Liu; Taishan Zheng; Niansong Wang; Feng Wang; Ming Li; Jiamei Jiang; Ruie Zhao; Lifang Li; Weijing Zhao; Qihan Zhu; Weiping Jia
Journal:  Mol Cell Biochem       Date:  2008-11-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.